Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Avbp Q4 2025 Earnings Arrivent Biopharma Inc. Tops Eps Views No Revenue 20260403 1 Is Twilio Twlo Stock Near A Bottom Price At 130.95 Up 0.38 20260402 Is Aios Tech Aios Stock Worth Buying Now Price At 0.56 Up 1.91 20260406 What Should Investors Watch In Fg Nexus Fgnx Stock Fgnx Q3 2025 Earnings Fg Nexus Inc. Reports 7.6 Eps Vs 0.612 Est No Revenue 20260408 1 Will Angel Angx Stock Grow In 2026 Price At 3.05 Up 2.01 20260406 Eaton EFT Stock Volume Ratio Weakens 20260415 BJs Rest BJRI Stock Prediction Whats Next Overhead Buying 20260418 cbdMD YCBD Stock Why It Could Surge Ticks Down 20260416 LouisianaPacific Corporation LPX Stock Is It Gaining Market Strength Q4 2025 Earnings Beat Estimates The growth trajectory Nouveau NMG is on and where it leads Edges Higher 20260511 Essential EPRT Stock Breaking Downtrend Flirts with Support 20260420 Lucid Group Inc LCID TakePrivate Speculation From Saudi PIF Emerges Amid Valuation Uncertainty and Recent Share Price Weakness The MA impact hidden in Compass COMP earnings Compass Defies Expectations with Profitable Quarter AI Disruption in Global Sports Talent Identification and Analytics Market Why Westrock WEST deserves a spot on your radar now Slow Grind 20260503 Centessa CNTA Stock Investment Risks Quiet 20260427 SPDR Gold Shares GLD Valuation Assessment Amid 8 PostIran War Gold Price Correction What Black Hills BKH management is not saying enough about 176 20260508 When is UBS Group UBS next earnings date and what matters most UBS Group delivers 52 EPS beat on core wealth management strength SP 500 Dow Futures Slide Up to 08 as Oil Prices Stay Elevated Brent Reaches 112 Waterdrop WDH Stock Slides 095 Support at 148 20260515 Barcelona Appoints First Overtourism Czar to Reclaim City from Mass Tourism Why Modi Urges Indians to Reduce Gold Purchases and Foreign Travel Amid Rupee Strain Canada to Review Amazon Contracts Following Quebec Warehouse Closures and Layoffs TD Bank Survey Finds 94 of Small Business Owners Confident in NearTerm Outlook MidCap MFICL Stock Analysis Flat at 2543 Whats Next 20260519 AXIL Brands AXIL Slides 513 as Selling Pressure Mounts 20260514 Indian Benchmarks Pare Early Gains as Investors Track West Asia Developments Dollar Slips on Iran Deal Hopes Yen Hovers Near Intervention Zone Shoals SHLS Reports Strong Q1 2026 Revenue NA EPS Beats Elutia ELUT Q1 2026 Results Profit Pressure Guidance Cut BP Removes Chair Albert Manifold Amid Governance Concerns Ian Tyler Named Interim Leader CBS Ends The Late Show Era Paul McCartneys Finale Highlights Financial Decision Behind Cancellation Huawei Unveils Logic Folding Chip Approach as Rivalry With Nvidia and Apple Intensifies GitHub Outages Threaten Microsofts AI Coding Edge as Competition Surges Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility AQMS Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges for PreRevenue Company GWAV Q3 2023 Earnings Loss per Share Reported at 175 as Company Focuses on Operational Improvements EWTX Q1 2026 Earnings EPS Beats Estimates as Clinical Pipeline Progresses GLAD Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite 2057 Surprise GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development Pfizer PFE Slips Marginally as Stock Tests Key Support Near 246 LanzaTech Global Warrants LNZAW Slide Further as Price Holds at Penny Levels Orchestra BioMed Holdings OBIO Slips Slightly as Stock Hovers Near Support NAC Trades Flat as Muni Bond Market Holds Steady Support and Resistance in Focus Virgin Galactic SPCE Q1 2026 Earnings A NarrowerThanExpected Loss Ignites Shareholder Optimism Snap Inc SNAP Q1 2026 Earnings Modest EPS Beat Amid Unreported Revenue Figures Root Inc ROOT Q1 2026 Earnings EPS Beats Estimates by 1436 as Profitability Surges KLAR Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues